Y-Intercept (HK)’s Indivior Pharmaceuticals INDV Stock Holding History

Y-Intercept (HK)’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.48M	Buy	180,667 +43,942	+32%	+$1.66M	0.14%	160
2026 Q2	$5.61M	Buy	+136,725	New	+$4.96M	0.11%	248
2025 Q4	–	Sell	-52,007	Closed	-$1.25M	–	1752
2025 Q3	$1.25M	Buy	52,007 +26,564	+104%	+$556K	0.03%	868
2025 Q2	$375K	Buy	25,443 +3,769	+17%	+$43.9K	0.01%	1295
2025 Q1	$207K	Buy	+21,674	New	+$228K	0.01%	1045
2024 Q3	–	Sell	-20,022	Closed	-$323K	–	1542
2024 Q2	$323K	Buy	+20,022	New	+$361K	0.02%	1013

Other funds holding INDV

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Y-Intercept (HK)'s INDV Position: Q3 2026 in Review

Y-Intercept (HK) increased its Indivior Pharmaceuticals (INDV) stake by 32% in Q3 2026, buying an estimated $1.66M and bringing the position to 180,667 shares worth $6.48M. The position accounts for 0.14% of the portfolio, ranked #160.

Y-Intercept (HK) first reported a position in INDV in Q2 2024 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold INDV as of Q3 2026.

Y-Intercept (HK) held 180,667 shares of Indivior Pharmaceuticals worth $6.48M as of Q3 2026.
Y-Intercept (HK) bought 43,942 Indivior Pharmaceuticals shares in Q3 2026, an estimated $1.66M.
Indivior Pharmaceuticals made up 0.14% of Y-Intercept (HK)'s portfolio in Q3 2026, its #160 holding.
Y-Intercept (HK) first reported a position in Indivior Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
80 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.